Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications Health Condition 2: E112- Type 2 diabetes mellitus with kidney complications Health Condition 3: E113- Type 2 diabetes mellitus with ophthalmic complications
Conditions
Interventions
Control Intervention1: Nil: Nil
Sponsors
Jayanthi S
Eligibility
Inclusion criteria
Inclusion criteria: Nil
Exclusion criteria
Exclusion criteria: Patients with previous and current malignant tumors Gestational diabetes and type 1 diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the association of HbA1C in cardiovascular and chronic kidney diseaseTimepoint: Baseline, Yearly once up-to 4 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess the prevalence of thyroid dysfunction among diabetic patients. Assess the prevalence of dyslipidemia in diabetic patients. Explore the potential interactions between HbA1C levels and other demographic or clinical variables such as age, gender, BMI, co-morbidities in relation to the mentioned health conditions. Timepoint: 3.5 years | — |
Countries
India
Contacts
Public ContactJayanthi S
Madras Medical Mission Hospital
Outcome results
None listed